Synchron, Inc.: Business Overview, Financials & Competitive Analysis
Synchron, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Synchron is positioned as a leading minimally-invasive brain-computer interface innovator backed by marquee institutional investors and partnering with Apple on next-generation consumer applications. Synchron is a well-funded, late-stage biotech company with meaningful clinical validation in brain-computer interfaces and a major tech partnership with Apple. Strong investor backing and recent Series.
What is Synchron, Inc.'s industry? Synchron, Inc. (synchron.com) operates in Neurostimulation Devices. AskCyborg classifies Synchron, Inc. under Neurostimulation Devices in its company registry.
Synchron, Inc. develops neurotechnology and medical devices focused on brain-computer interfaces, commercializing and scaling implantable BCI technology and conducting clinical research and trials for patients with pa...
Cyborg Score thesis
Synchron is positioned as a leading minimally-invasive brain-computer interface innovator backed by marquee institutional...
Read the full analyst-debate transcript →Get the Latest Synchron, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeSynchron, Inc. Overview
Pro stress-test →Synchron, Inc. develops neurotechnology and medical devices focused on brain-computer interfaces, commercializing and scaling implantable BCI technology and conducting clinical research and trials for patients with paralysis. The company offers a motor neuroprosthesis called the Stentrode which helps paralyzed patients regain the ability to communicate.
Strategic Profile
Pro stress-test →Synchron has raised $340M from 48 investors including 3cap, Armyn Capital, Axial Partners, and In-Q-Tel. The company completed a Series D funding round in November 2025 with participation from 12 investors. Apple is working with Synchron to develop devices including iPhones that could be controlled using brain implants and users' thoughts.
Competitive Landscape
Pro stress-test →Synchron faces competition from Precision Neuroscience, Neurable, Neuralink, Blackrock Neurotech, and Paradromics. Synchron differentiates through minimally-invasive catheter-based delivery and commercial-stage clinical programs, positioning it between early-stage research companies and Neuralink's more invasive surgical approach.
Industry Context
Synchron, Inc. operates in Neurostimulation Devices.
Key facts
Founded: 2016 · Headquarters: Brooklyn, US · Employees: 127